chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pharmacist administered 1 mL instead of 0.5 mL on accident. The pharmacy receives the Pfizer shot syringes (1 mL) and Moderna syringes (3 mL). The pharmacy received new syringe products for 5 mL and the labeling and color looked nearly identical to the 3 mL syringe. Unfortunately, in a chaotically busy retail pharmacy, where patients want their vaccines and medications quickly. I was trying to be quick and administered the vaccines in a 5 mL syringe. The graduations in the 5 mL syringes are by 1 mL, so 1,2,3,4,5 mL. Each mL increases in increments of 0.2 mL, so 0.2, 0.4, 0.6, 0.8 and 1 mL. In the usual syringe, the first bold graduation is 0.5 mL (for the 3 mL syringe). In the 5 mL syringe, the first bold graduation is 1 mL. I have been administering covid vaccines since February 2021. By habit, I drew up the vaccine to the first bold mark, but regretfully, this was 1 mL instead of 0.5 mL. My pharmacy manager and I are working on eliminating all syringes that are not suitable for measuring volume for the covid vaccine. We receive Pfizer and Moderna shot supplies via a large box that is automatically sent from corporate/CDC (to my knowledge). My pharmacy manager and I are both confused on why we would be sent vaccine supplies that are not suitable for covid vaccinations to begin with. It is almost like they are trying to create a situation for a pharmacist to measure an incorrect dose. Although, it is ultimately my fault, I was placed in a hazardous situation, both with the work environment (due to short staffing and unrealistic expectations) and with the incorrect syringe supplies.
Mother called on 8/6/2005, according to her right sided weakness noted on child. He was already seen at one hospital, recommended he be seen again at this ER and if needed MRI will be done as mother is requesting.
Pt had a syncopal episode several minutes after receiving the GARDASIL vaccine, while sitting on the exam table, she fell to the floor and hit her face. After approximately 20 mins pt was stable and discharged from office. Was instructed to see dentist, she chipped her  tooth when she hit the floor.
TDap vaccine administered as IM injection to (R) deltoid. Pt had immediate swelling/indention of about 3 cm circumference around injection site. Cold compress and BENADRYL 2 Sy IM given as treatment.
On the evening of 3/21/2021, several hours after I received the  2nd dose of the Pfizer vaccine, I had severe weakness, chills, and nausea. Upon waking up the next morning, I immediately began vomiting, and since I had not eaten anything yet, it was just bile (bright, neon yellow in color). I continued to vomit at least 6-7 times after that. I tried to eat something, but was unable to keep anything down. By mid-afternoon I called my clinic and, after explaining my symptoms to a nurse, she recommended that I come in immediately. I was given anti-nausea medications and Gatorade. This helped quite a bit and I felt completely normal the next day.
Vaccines had undergone several temperature excursions and administered to patient; No Adverse Event; Vaccines had undergone several temperature excursions and administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccines had undergone several temperature excursions and administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines had undergone several temperature excursions and administered to patient) and NO ADVERSE EVENT (No Adverse Event) in a 75-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     It was unknown whether patient had ever been diagnosed with or tested positive for COVID-19.     On 22-Sep-2022 at 11:26 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 22-Sep-2022 at 11:26 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccines had undergone several temperature excursions and administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines had undergone several temperature excursions and administered to patient) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccines had undergone several temperature excursions and administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines had undergone several temperature excursions and administered to patient) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Vaccines had undergone several temperature excursions and administered to patient) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines had undergone several temperature excursions and administered to patient).    No concomitant medications were provided by the reporter.  The patient received 3 primary doses of Moderna vaccine intramuscular in deltoid.  Vaccine 4th dose reported as 0.5 in Deltoid muscle. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022. The Moderna and Bivalent vaccines have undergone several temperature excursions and might got administered to patients.  No adverse reactions reported to any patient.  No treatment medications were provided by the reporter.
pt recv vax; exp rash w/ 3 pox on back; pox resolved w/in 1 wk;6mar96 devel 2 more pox on back w/ HA,sore throat & malaise;MD felt pt had devel shingles;
Lightening bolt pain traveling down legs, pins and needles ricocheting between legs, intermittent numbness
This spontaneous report was received from a Rheumatologist (also referred as Physician Assistant), concerning a 52 year old male patient. Information about the patient's medical history and concurrent conditions was not provided. The patient had no drug reactions or allergies. On an unknown date, as a child, the patient was vaccinated with his first dose of M-M-R II (administration route, lot number and expiration date were not provided). On an unspecified date in 2015 reported as "sometime last year", the patient was latter vaccinated with a second dose (administration route, lot number and expiration date were not provided). According to the reporter it was not sure if the patient received the second dose series due to a "history of an unknown lymphoma", or if it was given due to a job requirement. The reporting Physician Assistant was not sure if the patient's lymphoma came prior to or after the administration of the first series of M-M-R II. The reporter also stated that on approximately June 2016, reported as "last week", the patient got his titers drawn, which showed that the patient was immune to everything, but the measles (antibody test negative). No Product Quality Complaint (PQC) was involved. The outcome of lymphoma and antibody test negative was unknown at the time of this report. The reporter did not provide a causality assessment between the events and therapy with M-M-R II. Additional information is not expected, as there was no consent given to contact the physician.
Pt said the night after getting her flu vaccine, she started itching and developed a rash on her trunk and face.  The next morning at 11 am, she took a 25mg Benadryl and it took some of the edge off, but she was still really red.  By 4:30pm she was here at the pharmacy and was very itchy.  She had no problems with breathing or her throat swelling at any point during the reaction.  We called her physician and they told her to go home and take 50mg Benadryl and call them the next day.  Pt did end up seeing md the next day and was prescribed prednisone and triamcinolone.
Patient had FLUZONE HD on 9/20/16. She developed hematoma (bruises) on the upper arm on 9/22/16. She came to pharmacy today. Patient didn't complain any pain or swelling. The bruise started to fade as of 9/23. Per pt. the bruise didn't get bigger comparing to yesterday.
Pain; Loss of function; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 4X733, expiry date 8th March 2021) for prophylaxis.   On 18th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient received injection of Shingrix in an unknown arm 5 weeks ago from the date of reporting.  At the time of reporting, the patient's arm was sore. The patient complained of pain in the arm injected with loss of function. The patient was using their unaffected arm to move the affected arm.  The pharmacist stated that, the patient received other injections but did not specify name or type. No additional details were provided.
pt complained of having neurological symptoms the day of the vaccine and the next day. States she was having pain and tingling on her left side along with vertigo and just feeling off.
The pharmacist accidentally administered 2 doses of the Covid Pfizer Bivalent booster to the patient. Patient did not receive the flu shot. Pharmacy will call the patient daily to check on his condition.
A few minutes after getting her shot and getting up from being seated, the patient experienced ringing in her ears, lightheadedness, and black vision. This lasted for a few minutes. She felt like passing out. Upon blood pressure check, her BP was 99/50 and pulse was 60.
Second dose wasn't received and more than 36 days have passed since then; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose wasn't received and more than 36 days have passed since then) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose wasn't received and more than 36 days have passed since then). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose wasn't received and more than 36 days have passed since then) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that "she missed second dose because this day she stayed in hospital for reason not related to vaccination".  No concomitant medication was not reported. No treatment medication was not reported
pt recv vax 6APR96 & 20APR96 pt exp rash & mild fever;pt irritable & had diff sleeping;
Bruise; Energy decreased; FEVER; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), ASTHENIA (Energy decreased), PYREXIA (FEVER) and MYALGIA (Body aches) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21-A) for COVID-19 vaccination.     The patient's past medical history included Bipolar disorder since an unknown date.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced CONTUSION (Bruise), ASTHENIA (Energy decreased), PYREXIA (FEVER) and MYALGIA (Body aches). At the time of the report, CONTUSION (Bruise), ASTHENIA (Energy decreased), PYREXIA (FEVER) and MYALGIA (Body aches) outcome was unknown.            Patient stated that she is treated with Tylenol for symptoms. Concomitant medications include Bipolar medications.
vasovagal response, seizure lasting 15 seconds approx. vitals were taken, Neuro assessment all within normal limits
This spontaneous report was received from a medical assistant refers to multiple unspecified patients of unknown gender and age. Information regarding the patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, these patients were vaccinated with doses of improperly stored GARDASIL (lot # K007828, expiry date: 02-MAR-2017). Medical assistant reported that the vaccines went to 31.8 F for 7 hours and 45 minutes. They were logged by a data logger and there were no prior excursions. the vaccines were back in range. No adverse effects were reported. This is one of five reports received form the same reporter. Additional information has been requested.
Because Cimzia is an immune-suppressive treatment, it is contraindicated when any infection is present.  I was due for an injection the week I developed symptoms.  Also I could not receive the dose due October 10th because I was still symptomatic and the home diagnostic test was still positive.  In the meantime my rheumatoid arthritis flared very badly.  Prior to the COVID-19 infection and the rheumatoid arthritis flare I was fairly active:  I was walking 4 miles three or four times a week.  Now my joints are swollen and very painful:  I cannot walk across the room without severe pain, particularly in my hips and knees.  To alleviate the pain some I am taking both tramadol and oxycodone, with only minimal relief.  Still my activity is extremely limited too.
Approx. 9:00 am client given H1N1 (lot UP052AA, exp 5/5/11). Waited time (10 mins) then went back to class. Returned stating arm was puffy, redden, warm. Referred to site nurse. After call to doctor client told to take Benadryl offered by site nurse.
Facial swelling/pallor within 24 hour of immunizations. Fussiness x 48 hours after immunizations.
worst migraine; body aches; chills; worst migraine/today he got another migraine/last night it hurt so bad could barely open his eyes; sweating; no appetite/having a hard time keeping stuff down/can't eat/appetite is diminished; he lost 10 pounds; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101482270 (pfizer).  A 27 year-old male patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 20Oct2021 (Batch/Lot number: unknown) at the age of 27 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Tested positive for Covid" (unspecified if ongoing), notes: he tested positive for Covid a while back before the vaccine. There were no concomitant medications. The following information was reported: MIGRAINE (non-serious) with onset 20Oct2021, outcome "unknown", described as "worst migraine/today he got another migraine/last night it hurt so bad could barely open his eyes"; PAIN (non-serious) with onset 21Oct2021, outcome "not recovered", described as "body aches"; CHILLS (non-serious) with onset 21Oct2021, outcome "not recovered", described as "chills"; HYPERHIDROSIS (non-serious) with onset Oct2021, outcome "unknown", described as "sweating"; DECREASED APPETITE (non-serious) with onset Oct2021, outcome "unknown", described as "no appetite/having a hard time keeping stuff down/can't eat/appetite is diminished"; WEIGHT DECREASED (non-serious) with onset Oct2021, outcome "unknown", described as "he lost 10 pounds"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "worst migraine". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reporter stated that ever since last week, nothing sounds good to him. his appetite is diminished. Reporter also stated that "from last week, he lost 10 pounds. Reporter also stated that patient was having chills though his temperature feels normal and he gets goosebumps. Reporter asked if appetite loss was reported side effect with the Pfizer COVID-19 vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Menstrual issues, two cycles; A little nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of MENSTRUATION IRREGULAR (Menstrual issues, two cycles) and NAUSEA (A little nausea) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017E21A and 006DZ1A) for COVID-19 vaccination.     Concomitant products included VITAMIN C [ASCORBIC ACID], VITAMIN D NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NAUSEA (A little nausea). In October 2021, the patient experienced MENSTRUATION IRREGULAR (Menstrual issues, two cycles). At the time of the report, MENSTRUATION IRREGULAR (Menstrual issues, two cycles) and NAUSEA (A little nausea) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that, the patient started having some menstrual issues after receiving the second dose. She states that she had always been regular, but now she had two cycles on Oct-2021, two cycles on Nov-2021 and two cycles on Dec-2021.  No treatment was provided.   This case was linked to MOD-2022-451952 (Patient Link).
Rash on face neck and chest, then spread to entire body.  No fever. No treatment.
Client received her vaccines at 3:25 pm while sitting in a chair. She moved to the exam table so her brother could receive his vaccines. While the brother was reeiving his vaccines Client passed out and fell off the table hitting her brothers knee before landing on the carpet. She was unresponsive with moaning and flexion on arms and legs eyes open for less than a minute. She than was responsive to mothers voice and became able to talk and move without problem. Given ice for abrasion on Left temple. Given crackers and water. By 3:40 pm client able to return to exam table and lie on back with legs elevated. Remained alert and oriented. Orginially c/o pain in knee but no further c/o when position changed.  Signs and symptoms of concussion, from CDC, given to mother as a precaution. Client stayed in the clinic until 4:00pm when she left with her mother and siblings. Her gait steady. 7/20/2012 telephone call to home. Client answered the phone, stating she was fine and had no problems.
PATIENT STARTED ITCHING 10MINUTES AFTER INJECTION WITH 0.5ML OF VACCINATION- PHARMACIST ADMISTERED 10ML OF BENADRYL LIQUID- PT STOPPED ITCHING 5 MINUTES AFTERWARDS
Pt reported dizziness about 5  min after receiving vaccine.  BP on exam was 75/32; 5 min later 64/34; EMS contacted due to downward trend;  BP returned to normal range within 15-20 min at 94/48; 101/66; 104/71 at subsequent checks. BG checked by EMS WNL.  Pt began feeling better and plan of action decided by the pt and EMS was to self monitor at home if symptoms returned to go ER.
severely edematous and protruding veins in AC space of left arm, also marked edema and bruising to left hand, resolved the next day
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 11-MAY-2015 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (lot # K004148, expire date 10-MAY-2015, 0.5 ml, once) intramuscularly. No adverse effect was reported. No product quality complaint (PQC) was involved. Additional information has been requested.
4/11/21 6:30 p.m. - Started feeling very tired, weak.   4/12/21  1:30 a.m. - extreme chills, couldn?t get warm.  4:30 a.m.. - woke up, felt that my body was on fire.  Struggled to get to the bathroom, could hear my heart pounding in my ears, had a terrible headache. I wasn?t able to move for about 45 minutes, I felt so sick and weak. Finally managed to get a thermometer, my temp was 102(my normal temp is 96). Finally got back to sleep only to wake up every hour (for about 8 hours) with intense need to urinate excessively each time. I was unable to get out of bed for 3 days, headache the entire time. I am still tired and weak .
BURNING ON SHOULDER; FELT PAIN; This spontaneous report received from a patient concerned a 93 year old female. The patient's height, and weight were not reported. The patient's past medical history included shingles. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination at right arm. No concomitant medications were reported. On 25-MAR-2021, the subject experienced burning on shoulder. On 25-MAR-2021, the subject experienced felt pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from felt pain, and burning on shoulder. This report was non-serious.
Pt recvd DTP #5 on 26MAR92; pt devel erythema & induration @ inject site that reached maximum site on 28MAR92;  pt had assoc temp of 102.8; improved over 48 hrs;
immun given 4APR94 on 7APR94 pt seen by MD dx ear infect & ATB prescribed; 8APR94 pt had unusual cry & inconsolable for 2-3 hrs; pt seen by MD on same date-phenergan w/codiene prescribed;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Dec2021 as dose 3 (booster), single (Lot number: FF8841) at the age of 41 years for covid-19 immunization; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 14Jan2021 as dose 1, single (Lot number: 027L20A) and on 11Feb2021 as dose 2, single (Lot number: 013M20A) for covid-19 immunization. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing). Concomitant medications within 2 weeks of Covid vaccine included: METFORMIN; ATORVASTATIN. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Jun2022) Negative, notes: tested negative on 28Jun2022; (01Jul2022) Positive, notes: tested positive for Covid on 01Jul2022. Therapeutic measures were taken as a result of covid-19 with Paxlovid from 19Jun2022 to 24Jun2022.  Additional information: The patient had covid-19 rebound and was administered with Paxlovid from 19Jun2022. The patient was tested negative on 28Jun2022, noted nasal congestion on 30Jun2022 and later tested positive for Covid on 01Jul2022.  No follow-up attempts are possible. No further information is expected.